Andrew D Dickinson is Chief Financial Officer of GILEAD SCIENCES, INC.. Currently has a direct ownership of 132,373 shares of GILD, which is worth approximately $11.9 Million. The most recent transaction as insider was on Mar 10, 2023, when has been sold 10,419 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K
4.71% 3M change
24.25% 12M change
Total Value Held $11.9 Million

Andrew D Dickinson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2023
BUY
Exercise of conversion of derivative security
-
10,419 Added 8.24%
116,037 Common Stock
Feb 15 2023
BUY
Grant, award, or other acquisition
$21,198 $56.38 p/Share
376 Added 0.35%
105,618 Common Stock
Feb 06 2023
SELL
Payment of exercise price or tax liability
$45,857 $86.36 p/Share
531 Reduced 0.5%
105,242 Common Stock
Feb 06 2023
BUY
Exercise of conversion of derivative security
-
1,817 Added 1.69%
105,773 Common Stock
Jan 24 2023
SELL
Payment of exercise price or tax liability
$1,287,774 $84.02 p/Share
15,327 Reduced 12.85%
103,956 Common Stock
Jan 24 2023
BUY
Grant, award, or other acquisition
-
66,202 Added 35.69%
119,283 Common Stock
Dec 10 2022
SELL
Payment of exercise price or tax liability
$42,225 $87.97 p/Share
480 Reduced 0.69%
69,215 Common Stock
Dec 10 2022
BUY
Exercise of conversion of derivative security
-
1,027 Added 1.45%
69,695 Common Stock
Nov 10 2022
SELL
Payment of exercise price or tax liability
$70,292 $82.6 p/Share
851 Reduced 1.22%
68,668 Common Stock
Nov 10 2022
BUY
Exercise of conversion of derivative security
-
1,912 Added 2.68%
69,519 Common Stock
Sep 10 2022
SELL
Payment of exercise price or tax liability
$31,073 $65.28 p/Share
476 Reduced 0.7%
67,607 Common Stock
Sep 10 2022
BUY
Exercise of conversion of derivative security
-
1,027 Added 1.49%
68,083 Common Stock
Jun 10 2022
SELL
Payment of exercise price or tax liability
$119,597 $60.74 p/Share
1,969 Reduced 2.85%
67,056 Common Stock
Jun 10 2022
BUY
Exercise of conversion of derivative security
-
4,672 Added 6.34%
69,025 Common Stock
Mar 10 2022
SELL
Payment of exercise price or tax liability
$208,628 $57.92 p/Share
3,602 Reduced 5.33%
64,005 Common Stock
Mar 10 2022
BUY
Exercise of conversion of derivative security
-
7,901 Added 10.46%
67,607 Common Stock
Feb 15 2022
BUY
Grant, award, or other acquisition
$18,141 $52.13 p/Share
348 Added 0.54%
64,353 Common Stock
Feb 06 2022
SELL
Payment of exercise price or tax liability
$49,011 $63.9 p/Share
767 Reduced 1.27%
59,706 Common Stock
Feb 06 2022
BUY
Exercise of conversion of derivative security
-
1,817 Added 2.92%
60,473 Common Stock
Jan 26 2022
SELL
Payment of exercise price or tax liability
$243,501 $67.34 p/Share
3,616 Reduced 5.81%
58,656 Common Stock
Jan 26 2022
BUY
Grant, award, or other acquisition
-
32,176 Added 34.07%
62,272 Common Stock
Nov 10 2021
SELL
Payment of exercise price or tax liability
$58,568 $67.32 p/Share
870 Reduced 2.24%
38,015 Common Stock
Nov 10 2021
BUY
Exercise of conversion of derivative security
-
1,913 Added 4.69%
38,885 Common Stock
Aug 15 2021
BUY
Grant, award, or other acquisition
$55 $55.08 p/Share
1 Added 0.0%
36,972 Common Stock
Jun 10 2021
SELL
Payment of exercise price or tax liability
$111,210 $69.29 p/Share
1,605 Reduced 4.16%
36,971 Common Stock
ADD

Andrew D Dickinson

Chief Financial Officer
Foster City, CA

Track Institutional and Insider Activities on GILD

Follow GILEAD SCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD